Highlighted

JLABS @ Toronto

Watch the video

JLABS @ Toronto

Our Residents

45 Resident Companies

See all companies
 
 
 
 
48 %
Therapeutics
 

So far, the JLABS experience has been incredible; really a game-changer for Immune Biosolutions!

Immume solutions
 
 
 
 
27 %
Medical Devices / Diagnostics / Vision Care
 

The more direct benefit and the most valuable one that we received for being a JLABS resident company is access to a world class network of investors and industry partners.

Nanovista
 
 
 
 
9 %
Digital Health
 

JLABS provides unprecedented access to industry leadership within the context of an agile and innovative atmosphere that is essential for startups to grow.

Nanovista
 
 
 
 
16 %
Consumer Health
 

As a startup you need to move beyond your core technical expertise and balance that with running a business. JLABS has helped with that balance by providing us access to expertise and technology that bring our ideas to life.

Nanovista
Apply to be part of JLABS @ Toronto
See all 45 companies and 13 alumni

 

Impact

Bringing expertise to Canada

267+
Meetings

Facilitated for JLABS companies or external Canadian healthcare companies with an investor.

“JLABS is a shining example of the importance of strategic industry partners in the creation of a sustainable life-sciences innovation economy. It's more than beautiful lab space and a cool coffee bar, its about creating a community of like-minded people intent on fostering innovation that can be scaled to solve important problems in healthcare. Thanks JLABS!”

- Dawn Bell - Chief Scientific Officer and Vice-President, Scientific Affairs, Novartis Pharmaceuticals Canada Inc.
“Being an alumni of the University of Waterloo, I know the great technology that exists in Canada, which is why I want to come back and teach entrepreneurs what I have learned in Silicon Valley. It is also why S28 has allocated $2M to invest in JLABS companies that meet our investment criteria. JLABS is a perfect partner for Spectrum28 because the companies have been reviewed by a committee of scientific experts within J&J.”

- Lyon Wong, Co-founder & General Partner, Spectrum 28

16
Investors taking part in JLABS Investor Hub

BDC Bloom Burton Cpoint Capital Epic capital Exelerate capital Genesys capital iGan Partners Lumira capital Mars Novatio
Omers OCE Ontario Pool global partners Versant ventures Whitecap

(Listed investors come to JLABS @ Toronto once
a month for 2-3hrs to meet with resident companies)

Activation Impact across Canada

112+
Events hosted

9,000+
Attendees

85+
J&J INNOVATION ENGAGEMENTS
across Canada since 2016

350+
Internal JNJ Expert Days

(Directors & VPs travelled globally to provide mentorship to our JLABS Companies)

I really enjoyed the opportunity itself to apply and meet with investors I wouldn’t otherwise have access to, like AbbVie Ventures today. Please keep up the good work! And schedule more VC's for 2017.

Just a note of sincere thanks. The quality of the speaker and the content was timely, relevant and useable information, also the JLABS space & organization of the event was impressive. My thanks for the time they put into these events.

I felt all of the speakers were incredibly prepared and I got a lot out of the experience in general. The speakers were approachable after the event and offered practical advice to our questions. The event was thoughtfully structured and it was great to have so many interesting people in the room.

See Upcoming JLABS @ Toronto Events

 

News

Servier and Treventis begin strategic research partnership in neurodegenerative diseases Cyclica and Translatum Medicus inc (TMi) Announce Partnership to Advance Small Molecule Discovery for Age-Related Macular Degeneration Johnson & Johnson Innovation Champions Leading Edge Science with 15 New Collaborations with Potential to Impact Patients’ Lives – Including JLABS @ Toronto Resident Winterlight Labs MedChart, Eve Medical part of HealthTech projects funded by $5.47 million from Ontario PreCAAP Company: Tracery Opthalmics Wins $50K First Prize at JLABS AI for Drug Discovery QuickFire Challenge Ontario Genomics invests in renewable chemicals MLA48 II announces its inaugural investment in Waterloo-based skin cancer detecting startup Suncayr Kalgene's Series A marks start of Lumira Capital’s next chapter Breast density results must be shared with patients, say advocates (Densitas, Inc) ImmunoBiochem Corporation Announces the Completion of a New Round of Financing and Residency at Johnson & Johnson Innovation, JLABS @ Toronto Appili Therapeutics Receives $1.2M USD from the Department of Defense to Advance Antibiotic Targeting Drug-Resistant Bacteria Toronto-based Analytics 4 Life raises $25 million in Series B financing to develop and ultimately commercialize their non-invasive cardiovascular diagnostic JLABS @ Toronto resident company Analytics 4 Life designated as a FierceMedTech's Fierce 15 for 2017 Deep Genomics Raises $13 Million To Develop Genetic Medicines AI meets life sciences: Ontario bets on WinterLight Labs Catching “Genetic Typos” with Toronto-Based DNAstack In Canada's stem cell factory, AI would help patrol the line
           

Photos

Our story:
Ontario welcomes JLABS

JLABS @ Toronto
MaRS Centre, West Tower
661 University Avenue, Suite 1300
Toronto, Ontario, Canada
M5G 0B7
647-243-5200
Get directions

As the first JLABS to open outside the United States, JLABS @ Toronto joins a network of life science facilities that are based throughout the United States in San Diego (the flagship JLABS), San Francisco, Boston and Houston.

These facilities are home to over 140 early-stage companies advancing pharmaceutical, medical device, consumer and digital health programs. JLABS @ Toronto is located on the 13th floor in the MaRS West Tower and is a collaboration among Johnson & Johnson Innovation, The University of Toronto, MaRS Discovery District, Janssen Inc., MaRS Innovation, and the Government of Ontario. JLABS @ Toronto opened on May 11th, 2016, the 40,000-square foot facility includes cutting-edge, modular and scalable lab space, state-of-the-art equipment, with access to scientific, industry and capital funding experts.

The space also features JLABS' inaugural device and digital prototype lab that provides entrepreneurs with access to highly specialized tools and skills building programs to design and develop smart health technologies.

Share